Ligand validation:1NYR

THR: THREONINE

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
1NYR_THR_A_1004	64%	54%	0.18	0.98	1	0.8	-	-	2	0	100%	1
1NYR_THR_B_2004	53%	60%	0.211	0.975	0.85	0.68	-	-	2	0	100%	1
4QFP_THR_A_602	97%	45%	0.059	0.975	0.95	1.16	1	1	0	0	100%	1
3AB2_THR_O_501	95%	42%	0.081	0.987	0.95	1.28	1	2	0	0	100%	1
7BLH_THR_AAAA_201	95%	84%	0.071	0.976	0.45	0.31	-	-	0	0	100%	1
3S1T_THR_A_301	95%	44%	0.07	0.974	1.1	1.07	1	-	0	0	100%	1
2DTJ_THR_A_401	94%	29%	0.083	0.983	2.24	0.63	2	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.